3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
3
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Colorectal Neoplasms
5
Breast Neoplasms
4
Prostatic Neoplasms
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Smoking Cessation
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Motor Activity
1
Melanoma
1
Lung Neoplasms
1
Gastrointestinal Neoplasms
1
Colorectal Cancer Screening
1
Behavior
1
Interventions
pembrolizumab
36
Magnetic Resonance Spectroscopy
23
Gemcitabine
19
Specimen Handling
15
Nivolumab
12
Carboplatin
12
Surveys and Questionnaires
11
Paclitaxel
11
Cetuximab
11
Early Intervention, Educational
10
Bevacizumab
10
Standard of Care
9
Cyclophosphamide
9
Cisplatin
9
Radiosurgery
8
Methods
8
Fluorouracil
8
Docetaxel
8
Blood Specimen Collection
8
Psychiatric Rehabilitation
7
Pemetrexed
7
sargramostim
6
aldesleukin
6
Taxes
6
Injections
6
Fluorodeoxyglucose F18
6
Educational Status
6
Drug Therapy
6
Biopsy
6
Albumin-Bound Paclitaxel
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Motivational Interviewing
×
Gastrointestinal
×
Clear all
NCT05354882
2023-05-09
DEFACTO2
Université Sorbonne Paris Nord
Phase NA
Unknown
150 enrolled